You are here

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Westmead, Sydney, New South Wales, 2145 Australia
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Juvenile Idiopathic Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male and female subjects with a diagnosis per International League of Associations for
Rheumatology (ILAR) criteria of extended oligoarticular juvenile idiopathic arthritis
(JIA) between the ages of 2 and 17 years; enthesitis-related arthritis (ERA) between
the ages of 12 and 17 years; or psoriatic arthritis (PsA) between the ages of 12 and
17 years.

- >= 2 active joints and the following for the relevant JIA subtype: extended
oligoarticular JIA or PsA with a history of intolerance or an unsatisfactory response
to a disease modifying antirheumatic drug (DMARD); or ERA with a history of
intolerance or an unsatisfactory response to a nonsteroidal anti-inflammatory drug
(NSAID) or a DMARD.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Systemic JIA, persistent oligoarticular JIA, polyarticular JIA, or undifferentiated
arthritis per ILAR criteria.

- Other rheumatic diseases.

- Active uveitis within 6 months of the baseline visit.

- Any other significant health problem.

NCT00962741
Pfizer
Completed
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Juvenile Idiopathic Arthritis
NCT02592434
All Genders
2+
Years
Multiple Sites
Juvenile Idiopathic Arthritis
NCT01513902
All Genders
2+
Years
Multiple Sites
Juvenile Idiopathic Arthritis
NCT01500551
All Genders
2+
Years
Multiple Sites
Juvenile Idiopathic Arthritis
NCT01145352
All Genders
5+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now